Archives for the 'Blog' Category
Endosense is developing a catheter ablation treatment for cardiac rhythm disorders, including atrial fibrillation (AF). AF is the most common cardiac rhythm disorder today, affecting more than six million people worldwide.
Currently, most AF patients are […]
14 November 2008 |
Blog, news2, Video |
Regular Sentinel readers know I’m a fan of Endologix. The developer of a minimally invasive treatment for abdominal aortic aneurysms has had a slate of positive news of late. In addition to two new FDA […]
13 November 2008 |
Blog, news1, feature2 |
Only months after Healthtronics withdrew its offer to acquire Endocare for $2.28 per share, Endocare and privately held Galil Medical have agreed to merge. The combined company will be focused on the development of cryoablation […]
13 November 2008 |
Blog, Member Spotlight, news2 |
In June, Abiomed got the green light from the FDA to market its Impella 2.5 CAD, a minimally invasive ventricular assist device. At the time, I reported that the company could potentially double its revenues […]
12 November 2008 |
Blog, news2 |
One of the central problems in using chemotherapy to treat cancer is its harmful effect on organ health. Lower dosages of the drug are often used to limit side effects, which may diminish benefits of […]
10 November 2008 |
Blog, news2, Video |
In a recent filing, Cyberkinetics Neurotechnology said it only had enough cash to last 30 days. If negotiations fail with its secured creditor, GE Capital, the company will shut down and may seek bankruptcy protection.
At […]
7 November 2008 |
Blog, news1, Video, feature2 |
Having acquired onetime rival Diomed for a song, AngioDynamics has launched a new varicose vein therapy brand, VenaCure EVLT. The new brand combines AngioDynamics’ VenaCure with Diomed’s EVLT.
“As the name conveys, our new brand will […]
6 November 2008 |
Blog, news2, feature2 |
Symphony Medical, a privately-held company developing novel biocompatible polymer therapies to treat chronic heart failure and atrial fibrillation has raised $10 million in a Series C Round.
The company plans to raise an additional $15 million […]
5 November 2008 |
Blog, Member Spotlight, news2 |
Revenues at CryoLife rose 21% to $26.8 million in the third quarter of 2008. Net income was $3.6 million, or $0.13 per share, compared to $1.9 million, or $0.07 per share in Q3 2007.
Tissue processing […]
5 November 2008 |
Blog, Member Spotlight, news2 |
During times of economic malaise, discretionary income tends to decline. For many, it’s difficult to justify spending money on one’s appearance. Over the past several quarters, as consumers have cut back, investors have lost confidence […]
4 November 2008 |
Blog, news1, feature1 |
